b12 injection ingredients VITAMIN Vitamin b1, b6, and b12

Stop the medication if you are experiencing these symptoms and consult with your healthcare provider before taking the next dose

J Clin Endocrinol Metab 85 : 15181524 Acerini CL et al

AOD-9604 is administered via subcutaneous injection into fatty tissue, with the abdominal region being the preferred site

Neurological Effects : AOD 9604 peptide shows minimal neurological side effects compared to compounds that cross the blood-brain barrier more readily

Composition 5-amino-1MQ: 5 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Investigation of NNMT inhibition and its downstream metabolic effects Studies on NAD+ metabolism and energy homeostasis in preclinical models Development of analytical methods for small-molecule quantitation Stability and solubility assessment of 5-amino-1MQ under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability

note that daily dosing is only for the activation phase of the GLOW protocol (weeks 1-4) , decreasing to 5x per week for the remodelling phase (weeks 5-9), and further reduced to 2-3x per week during maintenance (weeks 9-12)